The promise of translational and personalised approaches for paediatric obstructive sleep apnoea: An 'omics' perspective

Thorax

Volumn 69, Issue 5, 2014, Pages 450-456

  Tan, Hui Leng ^a   Kheirandish Gozal, Leila ^b   Goza, David ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; BREATHING; CHILD; HEALTH; HUMAN; METHODOLOGY; MORBIDITY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PROGNOSIS; REVIEW; SLEEP; SLEEP DISORDERED BREATHING;

SLEEP APNOEA;

CHILD; HUMANS; MORBIDITY; PHENOTYPE; PROGNOSIS; RESPIRATION; RESPIRATORY THERAPY; SLEEP; SLEEP APNEA, OBSTRUCTIVE; WORLD HEALTH;

EID: 84898855483     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-204640     Document Type: Review

References (96)

1. Rosen CL, Larkin EK, Kirchner HL, et al. Prevalence and risk factors for sleep-disordered breathing in 8-to 11-year-old children: association with race and prematurity. J Pediatr 2003;142:383-9.
2. Bixler EO, Vgontzas AN, Lin HM, et al. Sleep disordered breathing in children in a general population sample: prevalence and risk factors. Sleep 2009;32:731-6.
3. Marcus CL, Brooks LJ, Draper KA, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2012;130:576-84.
4. Crabtree VM, Varni JW, Gozal D. Health-related quality of life and depressive symptoms in children with suspected sleep-disordered breathing. Sleep 2004;27:1131-8.
5. Garetz SL. Behavior, cognition, and quality of life after adenotonsillectomy for pediatric sleep-disordered breathing: summary of the literature. Otolaryngol Head Neck Surg 2008;138:S19-26.
6. Baldassari CM, Mitchell RB, Schubert C, et al. Pediatric obstructive sleep apnea and quality of life: a meta-analysis. Otolaryngol Head Neck Surg 2008;138:265-73.
7. Tauman R, Gozal D. Obstructive sleep apnea syndrome in children. Expert Rev Respir Med 2011;5:425-40.
8. Kheirandish-Gozal L, Gozal D, eds. Sleep disordered breathing in children. 1 edn. Springer Science, 2012.
9. Marcus CL, McColley SA, Carroll JL, et al. Upper airway collapsibility in children with obstructive sleep apnea syndrome. J Appl Physiol 1994;77:918-24.
10. Marcus CL, Moore RH, Rosen CL, et al. A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med 2013;368:2366-76.
11. Bhattacharjee R, Kheirandish-Gozal L, Spruyt K, et al. Adenotonsillectomy outcomes in treatment of obstructive sleep apnea in children: a multicenter retrospective study. Am J Respir Crit Care Med 2010;182:676-83.
12. Nath A, Emani J, Suskind DL, et al. Predictors of Persistent Sleep Apnea After Surgery in Children Younger Than 3 Years. JAMA Otolaryngol Head Neck Surg 2013;139:1002-8.
13. Marcus CL, Radcliffe J, Konstantinopoulou S, et al. Effects of positive airway pressure therapy on neurobehavioral outcomes in children with obstructive sleep apnea. Am J Respir Crit Care Med 2012;185:998-1003.
14. Marcus CL, Rosen G, Ward SL, et al. Adherence to and effectiveness of positive airway pressure therapy in children with obstructive sleep apnea. Pediatrics 2006;117:e442-51.
15. DiFeo N, Meltzer LJ, Beck SE, et al. Predictors of positive airway pressure therapy adherence in children: a prospective study. J Clin Sleep Med 2012; 8:279-86.
16. Kheirandish-Gozal L, Kim J, Goldbart AD, et al. Novel pharmacological approaches for treatment of obstructive sleep apnea in children. Expert Opin Investig Drugs 2013;22:71-85.
17. Kim J, Bhattacharjee R, Dayyat E, et al. Increased cellular proliferation and inflammatory cytokines in tonsils derived from children with obstructive sleep apnea. Pediatr Res 2009;66:423-8.
18. Goldbart AD, Mager E, Veling MC, et al. Neurotrophins and tonsillar hypertrophy in children with obstructive sleep apnea. Pediatr Res 2007;62:489-94.
19. Kheirandish-Gozal L, Serpero LD, Dayyat E, et al. Corticosteroids suppress in vitro tonsillar proliferation in children with obstructive sleep apnoea. Eur Respir J 2009;33:1077-84.
20. Kheirandish-Gozal L, Gozal D. Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome. Pediatrics 2008;122:e149-55.
21. Brouillette RT, Manoukian JJ, Ducharme FM, et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 2001;138:838-44.
22. Goldbart AD, Goldman JL, Li RC, et al. Differential expression of cysteinyl leukotriene receptors 1 and 2 in tonsils of children with obstructive sleep apnea syndrome or recurrent infection. Chest 2004;126:13-8.
23. Kaditis AG, Ioannou MG, Chaidas K, et al. Cysteinyl leukotriene receptors are expressed by tonsillar T cells of children with obstructive sleep apnea. Chest 2008;134:324-31.
24. Tsaoussoglou M, Lianou L, Maragozidis P, et al. Cysteinyl leukotriene receptors in tonsillar B-and T-lymphocytes from children with obstructive sleep apnea. Sleep Med 2012;13:879-85.
25. Goldbart AD, Krishna J, Li RC, et al. Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest 2006;130:143-8.
26. Kaditis AG, Alexopoulos E, Chaidas K, et al. Urine concentrations of cysteinyl leukotrienes in children with obstructive sleep-disordered breathing. Chest 2009;135:1496-501.
27. Dayyat E, Serpero LD, Kheirandish-Gozal L, et al. Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. Chest 2009;135:1142-9.
28. Goldbart AD, Goldman JL, Veling MC, et al. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 2005;172:364-70.
29. Goldbart AD, Greenberg-Dotan S, Tal A. Montelukast for children with obstructive sleep apnea: a double-blind, placebo-controlled study. Pediatrics 2012;130: e575-80.
30. Kheirandish L, Goldbart AD, Gozal D. Intranasal steroids and oral leukotriene modifier therapy in residual sleep-disordered breathing after tonsillectomy and adenoidectomy in children. Pediatrics 2006;117:e61-6.
31. Khalyfa A, Capdevila OS, Buazza MO, et al. Genome-wide gene expression profiling in children with non-obese obstructive sleep apnea. Sleep Med 2009;10:75-86.
32. Khalyfa A, Gharib SA, Kim J, et al. Transcriptomic analysis identifies phosphatases as novel targets for adenotonsillar hypertrophy of pediatric obstructive sleep apnea. Am J Respir Crit Care Med 2010;181:1114-20.
33. Sans CO, Crabtree VM, Kheirandish-Gozal L, et al. Increased morning brain natriuretic peptide levels in children with nocturnal enuresis and sleep-disordered breathing: a community-based study. Pediatrics 2008;121:e1208-14.
34. Li AM, Au CT, Ho C, et al. Blood pressure is elevated in children with primary snoring. J Pediatr 2009;155:362-8.
35. Khalyfa A, Gharib SA, Kim J, et al. Peripheral blood leukocyte gene expression patterns and metabolic parameters in habitually snoring and non-snoring children with normal polysomnographic findings. Sleep 2011;34:153-60.
36. O'Brien LM, Mervis CB, Holbrook CR, et al. Neurobehavioral implications of habitual snoring in children. Pediatrics 2004;114:44-9.
37. Kheirandish-Gozal L, Gozal D. Genotype-phenotype interactions in pediatric obstructive sleep apnea. Respir Physiol Neurobiol 2013;189:338-43.
38. Zhu Y, Au CT, Leung TF, et al. Effects of Passive Smoking on Snoring in Preschool Children. J Pediatr 2013;163:1158-62.
39. Kheirandish-Gozal L, Ghalebandi M, Salehi M, et al. Neighbourhood air quality and snoring among school-aged children. Eur Respir J Published Online First: 29 Aug 2013. doi: 10.1183/09031936.00113113
40. Gozal D, Nair D, Goldbart AD. Physical activity attenuates intermittent hypoxia-induced spatial learning deficits and oxidative stress. Am J Respir Crit Care Med 2010;182:104-12.
41. Goldbart AD, Row BW, Kheirandish-Gozal L, et al. High fat/refined carbohydrate diet enhances the susceptibility to spatial learning deficits in rats exposed to intermittent hypoxia. Brain Res 2006;1090:190-6.
42. Nair D, Ramesh V, Gozal D. Adverse cognitive effects of high-fat diet in a murine model of sleep apnea are mediated by NADPH oxidase activity. Neuroscience 2012;227:361-9.
43. Spruyt K, Sans CO, Serpero LD, et al. Dietary and physical activity patterns in children with obstructive sleep apnea. J Pediatr 2010;156:724-30, 730.
44. Spruyt K, Gozal D. A mediation model linking body weight, cognition, and sleep-disordered breathing. Am J Respir Crit Care Med 2012;185:199-205.
45. Mathew JL, Narang I. Sleeping too close together: Obesity and obstructive sleep apnea in childhood and adolescence. Paediatr Respir Rev Published Online First: 1 Oct 2013. doi: 10.1016/j.prrv.2013.09.001
46. Bhattacharjee R, Kim J, Kheirandish-Gozal L, et al. Obesity and obstructive sleep apnea syndrome in children: a tale of inflammatory cascades. Pediatr Pulmonol 2011;46:313-23.
47. Burckhardt IC, Gozal D, Dayyat E, et al. Green tea catechin polyphenols attenuate behavioral and oxidative responses to intermittent hypoxia. Am J Respir Crit Care Med 2008;177:1135-41.
48. Zlokovic BV. Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. JAMA Neurol 2013;70:440-4.
49. Kheirandish L, Row BW, Li RC, et al. Apolipoprotein E-deficient mice exhibit increased vulnerability to intermittent hypoxia-induced spatial learning deficits. Sleep 2005;28:1412-7.
50. Kaushal N, Ramesh V, Gozal D. Human apolipoprotein E4 targeted replacement in mice reveals increased susceptibility to sleep disruption and intermittent hypoxia. Am J Physiol Regul Integr Comp Physiol 2012;303:R19-29.
51. Kalra M, Pal P, Kaushal R, et al. Association of ApoE genetic variants with obstructive sleep apnea in children. Sleep Med 2008;9:260-5.
52. Gozal D, Capdevila OS, Kheirandish-Gozal L, et al. APOE epsilon 4 allele, cognitive dysfunction, and obstructive sleep apnea in children. Neurology 2007;69:243-9.
53. Wang Y, Zhang SX, Gozal D. Reactive oxygen species and the brain in sleep apnea. Respir Physiol Neurobiol 2010;174:307-16.
54. Gozal D, Khalyfa A, Capdevila OS, et al. Cognitive function in prepubertal children with obstructive sleep apnea: a modifying role for NADPH oxidase p22 subunit gene polymorphisms? Antioxid Redox Signal 2012;16:171-7.
55. Iannuzzi A, Licenziati MR, De MF, et al. C-reactive protein and carotid intima-media thickness in children with sleep disordered breathing. J Clin Sleep Med 2013;9:493-8.
56. Ingram DG, Matthews CK. Effect of adenotonsillectomy on c-reactive protein levels in children with obstructive sleep apnea: a meta-analysis. Sleep Med 2013;14:172-6.
57. Tatlipinar A, Cimen B, Duman D, et al. Effect of adenotonsillectomy on endothelin-1 and C-reactive protein levels in children with sleep-disordered breathing. Otolaryngol Head Neck Surg 2011;145:1030-5.
58. Villa MP, Ianniello F, Tocci G, et al. Early cardiac abnormalities and increased C-reactive protein levels in a cohort of children with sleep disordered breathing. Sleep Breath 2012;16:101-10.
59. Li AM, Chan MH, Yin J, et al. C-reactive protein in children with obstructive sleep apnea and the effects of treatment. Pediatr Pulmonol 2008;43:34-40.
60. Tauman R, Ivanenko A, O'Brien LM, et al. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 2004;113:e564-9.
61. Gozal D, Crabtree VM, Sans CO, et al. C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children. Am J Respir Crit Care Med 2007;176:188-93.
62. Van EA, Van HK, De Winter BY, et al. Sleep-disordered breathing and C-reactive protein in obese children and adolescents. Sleep Breath Published Online First: 3 Sept 2013. 10.1007/s11325-013-0890-8
63. Chu L, Yao H, Wang B. Impact of adenotonsillectomy on high-sensitivity C-reactive protein levels in obese children with obstructive sleep apnea. Otolaryngol Head Neck Surg 2012;147:538-43.
64. Kaditis AG, Alexopoulos EI, Kalampouka E, et al. Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 2005;171:282-6.
65. Gozal D, Kaditis AG, Khalyfa A, et al. Association between variants in CRP and IL-6 genes and susceptibility to OSA in children: A candidate-gene association study in European American and South-East European populations. Sleep Med 2014;15:228-35.
66. Gozal D, Wang M, Pope DW Jr. Objective sleepiness measures in pediatric obstructive sleep apnea. Pediatrics 2001;108:693-7.
67. Gozal D, Kheirandish-Gozal L. Obesity and excessive daytime sleepiness in prepubertal children with obstructive sleep apnea. Pediatrics 2009;123:13-8.
68. Gozal D, Serpero LD, Kheirandish-Gozal L, et al. Sleep measures and morning plasma TNF-alpha levels in children with sleep-disordered breathing. Sleep 2010;33:319-25.
69. Khalyfa A, Serpero LD, Kheirandish-Gozal L, et al. TNF-alpha gene polymorphisms and excessive daytime sleepiness in pediatric obstructive sleep apnea. J Pediatr 2011;158:77-82.
70. Gozal D, Kheirandish-Gozal L, Serpero LD, et al. Obstructive sleep apnea and endothelial function in school-aged nonobese children: effect of adenotonsillectomy. Circulation 2007;116:2307-14.
71. Bhattacharjee R, Kim J, Alotaibi WH, et al. Endothelial dysfunction in children without hypertension: potential contributions of obesity and obstructive sleep apnea. Chest 2012;141:682-91.
72. Chatsuriyawong S, Gozal D, Kheirandish-Gozal L, et al. Polymorphisms in nitric oxide synthase and endothelin genes among children with obstructive sleep apnea. BMC Med Genomics 2013;6:29.
73. Chatsuriyawong S, Gozal D, Kheirandish-Gozal L, et al. Genetic variance in Nitric Oxide Synthase and Endothelin Genes among children with and without Endothelial Dysfunction. J Transl Med 2013;11:227.
74. Groom A, Elliott HR, Embleton ND, et al. Epigenetics and child health: basic principles. Arch Dis Child 2011;96:863-9.
75. Yang IV, Schwartz DA. Epigenetic control of gene expression in the lung. Am J Respir Crit Care Med 2011;183:1295-301.
76. Kim J, Bhattacharjee R, Khalyfa A, et al. DNA methylation in inflammatory genes among children with obstructive sleep apnea. Am J Respir Crit Care Med 2012;185:330-8.
77. Tan HL, Gozal D, Wang Y, et al. Alterations in circulating T-cell lymphocyte populations in children with obstructive sleep apnea. Sleep 2013;36:913-22.
78. Tan HL, Gozal D, Samiei A, et al. T regulatory lymphocytes and endothelial function in pediatric obstructive sleep apnea. PLoS One 2013;8:e69710.
79. Chan Y, Fish JE, D'Abreo C, et al. The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation. J Biol Chem 2004;279:35087-100.
80. Kheirandish-Gozal L, Khalyfa A, Gozal D, et al. Endothelial dysfunction in children with obstructive sleep apnea is associated with epigenetic changes in the eNOS gene. Chest 2013;143:971-7.
81. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95.
82. Gozal D. Serum, urine, and breath-related biomarkers in the diagnosis of obstructive sleep apnea in children: is it for real? Curr Opin Pulm Med 2012;18:561-7.
83. Gharib SA, Khalyfa A, Abdelkarim A, et al. Integrative miRNA-mRNA profiling of adipose tissue unravels transcriptional circuits induced by sleep fragmentation. PLoS One 2012;7:e37669.
84. Gharib SA, Khalyfa A, Abdelkarim A, et al. Intermittent hypoxia activates temporally coordinated transcriptional programs in visceral adipose tissue. J Mol Med (Berl) 2012;90:435-45.
85. Gharib SA, Khalyfa A, Kucia MJ, et al. Transcriptional landscape of bone marrow-derived very small embryonic-like stem cells during hypoxia. Respir Res 2011;12:63.
86. Gharib SA, Dayyat EA, Khalyfa A, et al. Intermittent hypoxia mobilizes bone marrow-derived very small embryonic-like stem cells and activates developmental transcriptional programs in mice. Sleep 2010;33:1439-46.
87. Wilkins MR, Pasquali C, Appel RD, et al. From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (N Y) 1996;14:61-5.
88. Shah ZA, Jortani SA, Tauman R, et al. Serum proteomic patterns associated with sleep-disordered breathing in children. Pediatr Res 2006;59:466-70.
89. Jurado-Gamez B, Fernandez-Marin MC, Gomez-Chaparro JL, et al. Relationship of oxidative stress and endothelial dysfunction in sleep apnoea. Eur Respir J 2011;37:873-9.
90. Jurado-Gamez B, Gomez-Chaparro JL, Munoz-Calero M, et al. Serum proteomic changes in adults with obstructive sleep apnoea. J Sleep Res 2012;21:139-46.
91. Krishna J, Shah ZA, Merchant M, et al. Urinary protein expression patterns in children with sleep-disordered breathing: preliminary findings. Sleep Med 2006;7:221-7.
92. Gozal D, Jortani S, Snow AB, et al. Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. Am J Respir Crit Care Med 2009;180:1253-61.
93. Kheirandish-Gozal L, McManus CJ, Kellermann GH, et al. Urinary Neurotransmitters Are Selectively Altered in Children with Obstructive Sleep Apnea and Predict Cognitive Morbidity. Chest 2013;143:1576-83.
94. Kaditis AG, Alexopoulos EI, Damani E, et al. Urine levels of catecholamines in Greek children with obstructive sleep-disordered breathing. Pediatr Pulmonol 2009;44:38-45.
95. Kelly A, Dougherty S, Cucchiara A, et al. Catecholamines, adiponectin, and insulin resistance as measured by HOMA in children with obstructive sleep apnea. Sleep 2010;33:1185-91.
96. O'Driscoll DM, Horne RS, Davey MJ, et al. Increased sympathetic activity in children with obstructive sleep apnea: cardiovascular implications. Sleep Med 2011;12:483-8.